Amgen (AMGN) - Quick Stock Analysis скачать в хорошем качестве

Amgen (AMGN) - Quick Stock Analysis

Amgen just like other pharmaceutical stocks, you need to know what their product pipeline is set to be before investing with them. As noted in the video, when we talked about AbbVie, a large portion of their revenue was from Humira but when that patent runs out, and the drug goes generic, then its likely going to reduced dramatically. Humira's patent is due up here soon in the next few years so that we will like revisit in another video. You didn't come here for ABBV though, you came here for AMGN. This stock itself has some great potential and may be one to consider as a stock to watch and even a stock to buy pending their numbers come a little more down. Take a look at the video to see what we see and if Amgen is a stock you're considering getting into in 2021. Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. -------------------- Join our Patreon! -   / everythingmoney   Check out Charles Schwab and Create Your account today! : http://www.schwab.com/public/schwab/n... -------------------- *WANT BOOKS WE RECOMMEND FOR INVESTING* The Intelligent Investor: https://amzn.to/3athjmX One Up On Wall Street: https://amzn.to/2XYJeGf Beating The Street: https://amzn.to/3ixVXre -------------------- SUBSCRIBE: https://www.youtube.com/channel/UChBV... Video editing by Rohan and Sharvari (The Tweaky Tales) ⚠️⚠️⚠️⚠️⚠️Disclaimer⚠️⚠️⚠️⚠️⚠️ Our channel disclaimer can be found here: https://bit.ly/3n0NxuD